Tag: RFMD

Major Movers on June 10; STEL, IHS, FB, RFMD, MCD

Shares of Stellarone Corp. (NASDAQ: STEL) rallied about 16.35% by afternoon trade on Monday. The Company announced on Monday that it has agreed to be acquired by Union First Market Bankshares Corp in deal valued at about $445 million. According to the terms of the deal, Union First will offer one share against each share held in Stellarone, which translates into $19.50 or 20% premium over the closing stock price on Friday. The merger of Richmond Va. based Union First and Charlottesville Va. based Stellarone will result into a largest Virginia based community bank in term of deposits. The amalgamation will result into 146 branches, deposits worth $5.8 billion, loans worth $5.2 billion, and total assets are estimated to be at $7.1 billion.

Continue reading Major Movers on June 10; STEL, IHS, FB, RFMD, MCD

Major Movers on March 26; SONC, BRP, NFLX, PLCE, ZIOP, SVU, RFMD

Shares of Sonic Corporation (NASDAQ:SONC) rallied after the drive-in restaurant chain, late last evening reported fiscal second quarter non-GAAP earnings which came in-line with Street’s expectation as expenses fell. Revenue however fell marginally short of Street’s expectation.

Continue reading Major Movers on March 26; SONC, BRP, NFLX, PLCE, ZIOP, SVU, RFMD

Major Gainers and Losers in Mid-Day Trading on October 24; PNRA, BWLD, RFMD, GLW

Shares of Panera Bread Co. (NASDAQ: PNRA), a national bakery-café concept with 1,541 company-owned and franchise-owned bakery coffee locations in U.S. and Canada, are up sharply in trading today. At last check, PNRA shares were trading 6.88% higher at $171.37 on above average volume of 913,392. The stock hit an intra-day high of $172.08 in mid-day trading today.

Continue reading Major Gainers and Losers in Mid-Day Trading on October 24; PNRA, BWLD, RFMD, GLW

Major Gainers and Losers on September 11th; SNSS, UNFI, RFMD, SHFL, NAVB, AMD, PANW

Shares of Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS), a biopharmaceutical company engaged in the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers, surged in trading today after the company announced that it will implement a one-time, 225-patient sample size increase in its Phase 3 VALOR trial.

Continue reading Major Gainers and Losers on September 11th; SNSS, UNFI, RFMD, SHFL, NAVB, AMD, PANW